Joe Barchi received his Ph.D. in Synthetic/Marine Natural Products Chemistry from the University of Hawaii and was a postdoctoral fellow at Duke University. He then joined the National Cancer Institute as a staff fellow in the Laboratory of Medicinal Chemistry in 1988 where he rose to his current position of Senior Scientist/Principal Investigator and NMR Facility Head at the newly formed Chemical Biology Laboratory.

His main research interests are in synthetic medicinal chemistry as it relates to carbohydrate-based drug design, the development of novel sugar-conjugated nanoparticles and the high-resolution structural analysis of sugars, glycopeptides and small molecule drug candidates by NMR spectroscopy.

Neil Price has a Ph.D. from the University of London, and has postdoctoral experience at the Univ. of Geneva in Switzerland, Paul-Sabatier University in Toulouse, and the Complex Carbohydrate Research Center in Athens, GA. He held a faculty position the U. of Rochester, NY before moving to the NCAUR, Peoria.

His research includes carbohydrate chemistry and biochemistry, mass spectrometry, and microbial metabolism. He currently serves on the ARS National Chemical Patent committee, and has over 90 peer-reviewed research publications.

Dr. Martinez Duncker is 37 years old and born in Mexico City. He earned his MD degree in the Military Medical School in Mexico after which he went to Paris, France to earn his PhD degree in the Ecole Pratique des Hautes Etudes. He is Director of the Cell Dynamics Research Center of the Morelos State Autonomous University in Cuernavaca, Mexico where he leads the Glycobiology and Human Genetics Program. He also is founder and President of the Latin American Society of Glycobiology.

His research includes the identification of novel sialoproteins and sialolipids through this approach sheds light into novel functions of sialic acids during Th activation.

George Bousfield completed his PhD at Indiana University in 1981. He then pursued postdoctoral studies at the University of Texas, M.D. Anderson Cancer Center with Darrell Ward. He is currently the Dr. L.M. Jones Distinguished Professor in the Fairmount College of Liberal Arts and Sciences at Wichita State University, and director of the WSU Protein Core Facility. He has published more than 56 journal articles.

His research interests are follicle-stimulating hormone (FSH) and luteinizing hormone (LH), play central roles in the control of reproduction by connecting neuroendocrine hypothalamic/pituitary activities to gonadal function.

Ying Qing is a Principal Scientist in the Pharmaceutical group at Waters Corporation. She joined Waters Corporation since 2001, shortly after she received her Ph.D. from the Analytical Chemistry Department at Purdue University. She is a group leader in the Biopharmaceutical lab unit at Waters. Her group’s focus is on Protein Biotherapeutics characterization using UPLC/QTOF MS platform. The projects she is currently working on range from glycan profiling, peptide mapping and lately the Hydrogen Deuterium Exchange Mass Spectrometry for protein higher order structure analysis. She has extensive experience in Mass Spectrometry, Gas-Phase Ion Chemistry and Liquid Chromatography Separation Techniques.

Her research interest focus is on Protein Biotherapeutics characterization using UPLC/QTOF MS platform.

Professor Marzabadi completed her PhD at the University of Missouri – St. Louis and carried out postdoctoral studies at Hunter College- CUNY. She has been at Seton Hall University for the past 15 years and has been a Visiting Professor at Harvard University Medical School and a Visiting Researcher at Memorial Sloan Kettering Cancer Center. She has published numerous papers in the carbohydrate literature and currently serves as a Member at Large for the ACS Division of Carbohydrate Chemistry.

Her research interest includes the synthesis and biological evaluation of new carbohydrate structures with the capacity to act as immunomodulators.

Guijun Wang has completed her PhD in 1999 from Michigan State University and postdoctoral research at Yale University in 2002. She started her independent career as an assistant professor at the University of New Orleans in 2002. In 2012, she relocated to Old Dominion University (ODU), currently she is a professor of Chemistry and Biochemistry at ODU.

Her research interests include synthetic methodology development; asymmetric synthesis; and the synthesis and study of carbohydrate based self-assembling systems. She has co-authored 50 peer reviewed papers and is the co-inventor on 20 international and US patents.

Konrad Sandhoff completed his PhD in biochemistry in Munich. After research stays in Munich, Israel and the USA he became a full professor of biochemistry at the University of Bonn in 1979. Since 2007 he is a senior professor at the LIMES institute, Bonn.

Major Research Interests: Molecular life sciences: analysis and pathobiochemistry of lysosomal (glyco-)sphingolipid storage diseases, structure and function of lysosomal enzymes and lipid binding proteins, topology of endocytosis and glycolipid metabolism, and regulation of glycolipid biosynthesis. He has published more than 480 peer-reviewed papers. Among many other prizes he also received the International Glycoconjugate Organization Award (2005).

Jiahua (Jay) Xie has completed his PhD in Biophysics at the age of 31 from Zhejiang University and postdoctoral studies from Departments of Genetics and Horticultural Science, North Carolina State University. He served as a Senior Scientist at the Vector Research Inc. (a subsidiary of Vector Group Ltd) for five years. Currently, he is an Associate Professor in the Department of Pharmaceutical Sciences and the PI of the BRITE, NCCU. He has published more than 50 papers in reputed journals and has been serving as an editorial board member of Journal of Zhejiang University (Agriculture and Life Sciences).

His research areas include Asialo-rhuEPO, a non-hematopoietic recombinant human erythropoietin (EPO) derivative lacking sialic acid, has been reported to display broad tissue-protective effects against damage triggered by ischemia/reperfusion, hypoxia or cytotoxic agents in the brain, the heart, the kidneys and the liver.

Dr Tony Velkov completed PhD in 2000 from Monash University. His anti-infective discovery research is at the leading edge globally. He was awarded a NHMRC Research Fellowships in 2006, 2011 and 2014. The quality and impact of his independent research was recognized by the NHMRC with an Excellence Award in 2011. He has published over 50 papers in high-caliber journals, 3 book chapters and 15 conference presentations. The dynamic team he leads consists of 3 postdocs, 3 RAs and 9 PhD students. Over the last 6 years, he has obtained >$9M funding from the NIH, NHMRC and foundations.

His research includes Influenza a constant global burden to human health.

Barbara Klajnert-Maculewicz has completed her Ph.D in 2002 from the University of Lodz, Poland and postdoctoral studies from the McMaster University, Ontario, Canada. She is a professor at the University of Lodz, Poland and an external scientific member at Leibniz IPF in Dresden, Germany. She is a co-author of 2 books and 9 chapters in monographs. She has published more than 90 papers in reputed journals (h-index 23). In the years 2009-2012 she was the Management Committee Chair of COST Action TD0802 “Dendrimers in biomedical applications” that gathered 24 countries. She has been awarded L’Oréal-UNESCO Fellowship for Women in Science.

Her research interests include Anticancer drugs such as cytarabine (araC) belong to nucleoside analogues (NAs). NAs are commonly used in the treatment of acute myeloid leukemia, acute lymphocytic leukemia, and lymphomas.

Dr. Wu obtained his Ph.D degree with W. Pigman, who is the pioneer in glycoproteins, at New York Medical College; and had his postdoctoral training at E.A. Kabat’s Lab for quantitative immunochemistry, Columbia University Medical Center, New York. He joined as a faculty position at Texas A&M University in 1982; promoted as a full professor at Chang-Gung University since 1989; and as Emeritus Professor in 2011. Dr. Wu published over 120 polyvalent glycotopes related papers. He is the chief editor for three volumes of Molecular Immunology of Complex Carbohydrates 1 to 3 in Adv. Exp. Med. Biol. 228, 451, 705 (Springer Publisher).

His major interests are (i) Glycan purification and characterization; (ii) recognition factors of glycans; (iii) combining sites of lectins and antibodies. He received many Outstanding Research Awards (1997-2008) from government agents in Taiwan.